Skip to main content
. 2022 Apr 29;9:847361. doi: 10.3389/fmed.2022.847361

TABLE 4.

Colorectal cancer screening method by each specialty.

Factors Primary care physician (N = 77) Internist (N = 173) Resident physician (N = 135) General Surgeon (N = 102) Colorectal Surgeon (N = 23) Gastroent-erologist (N = 76) P-value
Screening method, N (%)
FOBT 45 (58.4) 86 (49.7) 57 (42.2) 42 (41.2) 7 (30.4) 27 (35.5) 0.020
CEA 8.4 (10.9) 29 (16.8) 4 (3.0) 17 (16.7) 2 (8.7) 5 (6.6) 0.001
CT colonography 0 (0.0) 8 (4.6) 6 (4.4) 5 (4.9) 5 (21.7) 7 (9.2) 0.003
Sigmoidoscopy and barium enema 12 (1.6) 8 (4.6) 15 (11.1) 26 (25.5) 2 (8.7) 7 (9.2) <0.001
Sigmoidoscopy 12 (1.6) 9 (5.2) 5 (3.7) 8 (7.8) 1 (4.1) 2 (2.6) 0.420
Colonoscopy 33 (42.9) 100 (57.8) 100 (74.1) 77 (75.5) 21 (91.3) 73 (96.1) <0.001
Available method, N (%)
No screening tool 11 (14.3) 5 (2.9) 0 (0.0) 2 (2.0) 0 (0.0) 0 (0.0) <0.001
FOBT 59 (76.6) 156 (90.2) 127 (94.1) 86 (84.3) 20 (87.0) 71 (93.4) 0.003
Sigmoidoscopy 16 (20.8) 78 (45.1) 98 (72.6) 61 (59.8) 15 (65.2) 41 (54.0) <0.001
Barium enema 31 (40.3) 113 (65.3) 105 (77.8) 75 (73.5) 19 (82.6) 58 (76.3) <0.001
Colonoscopy 39 (50.7) 133 (76.9) 126 (93.3) 87 (85.3) 23 (100.0) 72 (94.7) <0.001
CT colonoscopy 16 (20.8) 53 (30.6) 70 (51.9) 33 (32.4) 15 (65.2) 45 (59.2) <0.001

Data presented as percentage of screening method by each specialty. FOBT, fecal occult blood test; CEA, carcinoembryonic antigen; CT; computed tomography.